AS15 COVID-19 Chair: Skaiste Sendzikaite, Switzerland Co-chair: Sabrina Bressieux-Degueldre, Switzerland
O-097 Three-dimensional echocardiography and global longitudinal strain in the assessment of left ventricular function in children after PIMS-TS, Halszka Kamińska, Poland O-098 Increase in Kawasaki disease incidence observed in 30-year population-based study in Scandinavia, André Rudolph, Sweden O-099 Complete resolution of cardiac sequelae is seen in patients treated for paediatric multisystem inflammatory syndrome (PIMS) by 12 months, Sally Hall, UK O-100 A comparative study of cardiac involvement of Kawasaki Disease and Multisystem Inflammatory Syndrome post Covid (MISC) in children, Debadatta Mukhopadhyay, India O-101 Kawasaki disease in the time of COVID-19 – The International Kawasaki Disease Registry, Ashraf S Harahsheh, United States O-102 Anakinra in treatment of Pediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV2 infection (PIMS-TS) with cardiac involvement, Joanna Lea Friedman Gruszczynska, Poland
|